EARLYSENSE

EarlySense develops signal-processing technology. The company's lead product, EverOn, a contact-free early detection patient supervision system that measures, records, displays, and alerts heart and respiration rates, as well as bed entries and exits, patient motion, and quality of sleep from under the mattress. EarlySense Ltd. was founded in 2004 and is based in Ramat Gan, Israel with a research and development facility in Israel; and marketing offices in Boston, Massachusetts.
EARLYSENSE
Industry:
Biotechnology Health Care Medical Device
Founded:
2004-01-01
Address:
Ramat Gan, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.earlysense.com
Total Employee:
101+
Status:
Active
Contact:
(781) 373-3228
Total Funding:
140 M USD
Technology used in webpage:
IPv6 Facebook Sharer Cloudflare Network Error Logging Cloudflare SSL ReCAPTCHA V2 HubSpot CMS Hub Twitter Tweet Button Accelerated Mobile Pages Facebook Like Button Apple Whitelist
Similar Organizations
Gamida Cell
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Advisors List
Board_member
2011-01-01
Board_member
Board_member
Board_member
Board_member
Board_member
2017-01-01
Current Employees Featured
Avner Halperin Co-Founder & CEO & Board of Directors @ EarlySense
Co-Founder & CEO & Board of Directors
2019-01-01
Guy merger CTO, VP R&D, Israel General Manager @ EarlySense
CTO, VP R&D, Israel General Manager
2007-04-01
Amir chon VP of Operations @ EarlySense
VP of Operations
Dalia Argaman VP of Clinical and Regulatory Affairs @ EarlySense
VP of Clinical and Regulatory Affairs
Ziv Leinwand VP International Business Development @ EarlySense
VP International Business Development
2018-08-01
John Dragovits Senior Vice President @ EarlySense
Senior Vice President
2020-01-01
Founder
Investors List
BlueRed Capital
BlueRed Capital investment in Series H - EarlySense
Wells Fargo Strategic Capital
Wells Fargo Strategic Capital investment in Series H - EarlySense
JK&B Capital
JK&B Capital investment in Series H - EarlySense
Hotung Venture Capital
Hotung Venture Capital investment in Series H - EarlySense
Hill-Rom
Hill-Rom investment in Series H - EarlySense
Pitango Venture Capital
Pitango Venture Capital investment in Series H - EarlySense
CE Ventures (CEIIF)
CE Ventures (CEIIF) investment in Series H - EarlySense
Argo Capital Partners
Argo Capital Partners investment in Series H - EarlySense
Pitango Venture Capital
Pitango Venture Capital investment in Series G - EarlySense
Bank Hapoalim
Bank Hapoalim investment in Series G - EarlySense
Newest Events participated

Key Employee Changes
Date | New article |
---|---|
2020-02-24 | EarlySense Names Health Tech Veteran John Dragovits as New SVP of Strategic Partnerships |
Official Site Inspections
http://www.earlysense.com Semrush global rank: 3.42 M Semrush visits lastest month: 4.55 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "EarlySense"
EarlySense - Wikipedia
EarlySense was an Israeli medical device company with offices in the United States. It has sold its proprietary contact-free continuous monitoring technology to Hill-Rom, now Baxter International. See details»
EarlySense - Crunchbase Company Profile & Funding
EarlySense develops signal-processing technology. The company's lead product, EverOn, a contact-free early detection patient supervision system that …See details»
EarlySense - LinkedIn
EarlySense | 9,917 followers on LinkedIn. Continuous Oversight. Actionable Insights. | EarlySense is the global leader in contact-free, continuous monitoring solutions for the healthcare continuum.See details»
EarlySense - partners500
Web site www.earlysense.com US EarlySense HQ. Address: 135 Beaver Street Suite 211 Waltham, MA 02452 US Phone: (781) 373-3228 Fax: (781) 373-2367 Israel EarlySense …See details»
EarlySense 2025 Company Profile: Valuation, Funding & Investors
EarlySense General Information Description. Developer of patient monitoring systems designed to enhance patient safety and reduce the risk for general care patients. The company's system …See details»
EarlySense - Israeli Startup | Startup Nation Finder
Feb 1, 2021 EarlySense has developed a contact-free monitoring system designed to improve outcomes and reduce risk for a range of patient populations. The system can be used by hospitals, healthcare organizations, integrated …See details»
EarlySense - Contacts, Employees, Board Members, Advisors
EarlySense develops signal-processing technology, offers EverOn, a contact-free and early detection patient supervision system. ... Experience the new Crunchbase, powered by AI . …See details»
Healthcare’s Most Innovative Companies of 2020: EarlySense
Sep 24, 2020 EarlySense is committed to establishing CFCM as the global standard of care across the healthcare continuum. To date, EarlySense’s CFCM predictive health analytics …See details»
EarlySense - VentureRadar
EarlySense's patented sensor and advanced algorithms monitor and analyze cardiac, respiratory, sleep and motion parameters. Used in hospitals and healthcare facilities worldwide, …See details»
EarlySense - StartupHub.ai
Description: EarlySense has introduced an innovative continuous patient monitoring solution designed to enhance patient safety and reduce risk for general care patients. Founded in 2004, EarlySense is a dynamic, rapidly …See details»
EarlySense Company Profile - Office Locations, Competitors ... - Craft
EarlySense has 5 employees across 2 locations and $145 m in total funding,. See insights on EarlySense including office locations, competitors, revenue, financials, executives, …See details»
EarlySense - Overview, News & Similar companies | ZoomInfo.com
Who is EarlySense. EarlySense® is the global leader in contact-free, continuous monitoring solutions for the healthcare continuum. Used worldwide in hospitals, post-a cute care facilities …See details»
An early demise: The sad end of Israel’s EarlySense - ctech
Nov 21, 2022 EarlySense’s technology allows for continuous (more than 100 times per minute) monitoring of patient heart and respiratory rates without requiring physical contact with the …See details»
Live/Percept End of Life - Business Partners - info.earlysense.com
Dear Valued EarlySense Partners, On behalf of the entire EarlySense organization, thank you for your partnership. We want to make you aware that as of January 31, 2020 we will be …See details»
The Entrepreneur: Avner Halperin & EarlySense - CEO Today
Sep 27, 2017 Avner Halperin is an entrepreneur, business executive and a physicist. He is also a lecturer on Israeli hi-tech eco-system at the Hebrew University of Jerusalem. He is a father …See details»
EarlySense Careers and Employment | Indeed.com
Nov 21, 2019 EarlySense is a startup company that experienced rapid growth over the past three years. I feel that rating this growth organization against larger more stable organizations …See details»
EarlySense to Accelerate Growth in Remote Patient Monitoring …
WOBURN, Mass., Feb. 1, 2021 /PRNewswire/ -- EarlySense, the global leader in contact-free, continuous monitoring solutions across the healthcare continuum, announced today that it has …See details»
EarlySense - Physician-Patient Alliance for Health & Safety
The accuracy of the EarlySense system to continuously monitor heart rate and respiration rate were validated during clinical trials in sleep lab and ICU setting. 14 In addition, in a blinded …See details»
Earlysense sells its intellectual property rights for $30 million
Feb 1, 2021 EarlySense is a medical device company that was founded in 2004 by Dr. Danny Lange, Guy Sher, Yossi Gross, and Avner Halperin, and has raised $150 million so far. Hillrom …See details»
Voices: Matt Johnson, CEO, EarlySense - Home Health Care News
Sep 17, 2021 EarlySense® is the global leader in 100-percent contact-free, continuous monitoring solutions. Used worldwide in hospitals, post-acute care facilities and throughout the …See details»